Literature DB >> 19436946

Bisphosphonate administration prior to tooth extraction delays initial healing of the extraction socket in rats.

Hisato Hikita1, Ken Miyazawa, Masako Tabuchi, Masakazu Kimura, Shigemi Goto.   

Abstract

Bisphosphonates (BPs) are clinically used for the treatment of bone metabolic abnormalities because they are powerful inhibitors of bone resorption. Osteonecrosis of the jaw has been observed after tooth extraction in a considerable number of BP-treated cancer patients, but the reason for this is not known. We studied the effects of BP on extraction socket healing in rats that were pretreated with BP prior to tooth extraction. Male Wistar rats (approximately 5 weeks old) were divided into experimental (BP) and control groups. In both groups, maxillary right second molars were extracted under general anesthesia. BP group rats were injected with 50 microl (1.0 mg/kg) alendronate into the right buccal alveolar bone every 4 days for 14 days, starting 2 days before tooth extraction. Control group rats were injected with physiological saline instead of alendronate. Rats were euthanized 3, 7, 10 or 14 days after tooth extraction, and maxillary bones were collected. Bone morphometric analysis using microfocus X-ray CT images and calculation of bone-resorption parameters based on hematoxylin and eosin or TRAP-stained pathological sections of the molar region showed that new bone formation in the extraction socket was delayed in the BP group relative to the control group during the first 7 days after extraction. A subsequent increase in new bone formation showed that bone resorption in the BP rats was eventually inhibited. This delay in initial healing may explain the jaw osteonecrosis observed in some BP-treated cancer patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19436946     DOI: 10.1007/s00774-009-0090-6

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  33 in total

1.  Uptake by bone of pyrophosphate, diphosphonates and their technetium derivatives.

Authors:  S Bisaz; A Jung; H Fleisch
Journal:  Clin Sci Mol Med       Date:  1978-03

2.  Effectiveness of local delivery of alendronate in reducing alveolar bone loss following periodontal surgery in rats.

Authors:  I Binderman; M Adut; A Yaffe
Journal:  J Periodontol       Date:  2000-08       Impact factor: 6.993

3.  Enhancement of crude bone morphogenetic protein-induced new bone formation and normalization of endochondral ossification by bisphosphonate treatment in osteoprotegerin-deficient mice.

Authors:  M Tabuchi; K Miyazawa; M Kimura; H Maeda; T Kawai; Y Kameyama; S Goto
Journal:  Calcif Tissue Int       Date:  2005-09-28       Impact factor: 4.333

4.  Inhibition of tooth eruption in the rat by a bisphosphonate.

Authors:  R L Grier; G E Wise
Journal:  J Dent Res       Date:  1998-01       Impact factor: 6.116

Review 5.  Alveolar bone remodeling after tooth extraction in normal and osteopetrotic (ia) rats.

Authors:  T Iizuka; S C Miller; S C Marks
Journal:  J Oral Pathol Med       Date:  1992-04       Impact factor: 4.253

6.  Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia models.

Authors:  Y Azuma; H Sato; Y Oue; K Okabe; T Ohta; M Tsuchimoto; M Kiyoki
Journal:  Bone       Date:  1995-02       Impact factor: 4.398

7.  Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride.

Authors:  H I Harinck; O L Bijvoet; A S Plantingh; J J Body; J W Elte; H P Sleeboom; J Wildiers; J P Neijt
Journal:  Am J Med       Date:  1987-06       Impact factor: 4.965

8.  Treatment of Paget's disease by weekly infusions of 3-aminohydroxypropylidene-1,1-bisphosphonate (APD).

Authors:  P J Ryan; M Sherry; T Gibson; I Fogelman
Journal:  Br J Rheumatol       Date:  1992-02

9.  Cytochemical localization of tartrate-resistant acid phosphatase, alkaline phosphatase, and nonspecific esterase in perivascular cells of cartilage canals in the developing mouse epiphysis.

Authors:  A A Cole; F H Wezeman
Journal:  Am J Anat       Date:  1987-11

10.  Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients.

Authors:  Stephen T Sonis; Brynmor A Watkins; Gregory D Lyng; Mark A Lerman; Kenneth C Anderson
Journal:  Oral Oncol       Date:  2008-08-19       Impact factor: 5.337

View more
  20 in total

1.  Compromised osseous healing of dental extraction sites in zoledronic acid-treated dogs.

Authors:  M R Allen; D J Kubek; D B Burr; S L Ruggiero; T-M G Chu
Journal:  Osteoporos Int       Date:  2010-05-11       Impact factor: 4.507

Review 2.  The effects of bisphosphonates on jaw bone remodeling, tissue properties, and extraction healing.

Authors:  Matthew R Allen
Journal:  Odontology       Date:  2011-01-27       Impact factor: 2.634

3.  Ovariectomy stimulates and bisphosphonates inhibit intracortical remodeling in the mouse mandible.

Authors:  D J Kubek; D B Burr; M R Allen
Journal:  Orthod Craniofac Res       Date:  2010-11       Impact factor: 1.826

4.  Alendronate affects osteoblast functions by crosstalk through EphrinB1-EphB.

Authors:  E Shimizu; J Tamasi; N C Partridge
Journal:  J Dent Res       Date:  2011-12-15       Impact factor: 6.116

5.  Effects of local application of alendronate on early healing of extraction socket in dogs.

Authors:  Nikola Saulacic; Fernando Muñoz; Eizaburo Kobayashi; Vivianne Chappuis; Antonio Gonzáles-Cantalapiedra; Willy Hofstetter
Journal:  Clin Oral Investig       Date:  2019-07-26       Impact factor: 3.573

Review 6.  Updates on osteonecrosis of the jaw.

Authors:  Junro Yamashita; Laurie K McCauley; Catherine Van Poznak
Journal:  Curr Opin Support Palliat Care       Date:  2010-09       Impact factor: 2.302

Review 7.  Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw.

Authors:  J Compston
Journal:  Osteoporos Int       Date:  2011-10-14       Impact factor: 4.507

8.  Prevention of medication related osteonecrosis of the jaw after dentoalveolar surgery: An institution's experience.

Authors:  Onur Şahin; Birkan Tatar; Ceren Ekmekcioğlu; Toghrul Aliyev; Onur Odabaşı
Journal:  J Clin Exp Dent       Date:  2020-08-01

9.  Zoledronate inhibits ischemia-induced neovascularization by impairing the mobilization and function of endothelial progenitor cells.

Authors:  Shih-Hung Tsai; Po-Hsun Huang; Wei-Chou Chang; Hsiao-Ya Tsai; Chih-Pei Lin; Hsin-Bang Leu; Tao-Cheng Wu; Jaw-Wen Chen; Shing-Jong Lin
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

10.  Experimental development of bisphosphonate-related osteonecrosis of the jaws in rodents.

Authors:  Nicolau Conte Neto; Luis C Spolidorio; Cleverton R Andrade; Alliny S Bastos; Morgana Guimarães; Elcio Marcantonio
Journal:  Int J Exp Pathol       Date:  2013-02       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.